Epidemiologic, clinical characteristics, and risk factors for adverse outcome in multiresistant gram-negative primary bacteremia of critically ill patients

American Journal of Infection Control

Volumn 39, Issue 5, 2011, Pages 396-400

  Michalopoulos, Argyris ^a   Falagas, Matthew E ^a,b,c   Karatza, Dimitra C ^a   Alexandropoulou, Paraskevi ^a   Papadakis, Emmanuel ^a   Gregorakos, Leonidas ^a   Chalevelakis, George ^a   Pappas, Georgios ^a,d  

^a HENRY DUNANT HOSPITAL   (Greece)

^b ALFA INSTITUTE OF BIOMEDICAL SCIENCES AIBS   (Greece)

^c TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d Institute of Continuing Medical Education of Ioannina   (Greece)

Author keywords

gram negative bacteremia; ICU acquired infection; intensive care unit acquired infection; multiple drug resistance; Primary bacteremia

Indexed keywords

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTION; ADULT; ADVERSE OUTCOME; AGED; ARTICLE; ARTIFICIAL VENTILATION; CASE CONTROL STUDY; CLINICAL ARTICLE; CLINICAL FEATURE; COHORT ANALYSIS; CONTROLLED STUDY; CRITICALLY ILL PATIENT; FEMALE; GRAM NEGATIVE SEPSIS; GREECE; HOSPITALIZATION; HUMAN; INTENSIVE CARE UNIT; KLEBSIELLA PNEUMONIAE; KLEBSIELLA PNEUMONIAE INFECTION; MALE; MORTALITY; MULTIPLE ORGAN FAILURE; NONHUMAN; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTION; RISK FACTOR;

ACINETOBACTER BAUMANNII; AGED; ANTI-INFECTIVE AGENTS; BACTEREMIA; CASE-CONTROL STUDIES; COHORT STUDIES; CRITICAL ILLNESS; CROSS INFECTION; DIABETES MELLITUS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FEMALE; GREECE; HUMANS; INTENSIVE CARE UNITS; KLEBSIELLA PNEUMONIAE; MALE; MIDDLE AGED; PSEUDOMONAS AERUGINOSA; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 79957888962     PISSN: 01966553     EISSN: 15273296     Source Type: Journal    
DOI: 10.1016/j.ajic.2010.06.017     Document Type: Article

References (26)

1. Suljagic V, Cobeljic M, Jankovic S, Mirovic V, Markovic-Denic L, Romic P, et al. Nosocomial bloodstream infections in ICU and non-ICU patients. Am J Infect Control 2005;33:333-40. (Pubitemid 41078771)
2. Gaynes R, Edwards JR. Overview of nosocomial infections caused by gram-negative bacilli. Clin Infect Dis 2005;41:848-54. (Pubitemid 41266753)
3. Wroblewska MM, Rudnicka J, Marchel H, Luczak M. Multidrug-resistant bacteria isolated from patients hospitalised in intensive care units. Int J Antimicrob Agents 2006;2:285-9.
4. Kohlenberg A, Schwab F, Geffers C, Behnke M, Rüden H, Gastmeier P. Time-trends for gram-negative and multidrug-resistant gram-positive bacteria associated with nosocomial infections in German intensive care units between 2000 and 2005. Clin Microbiol Infect 2008;14:93-6.
5. Edgeworth JD, Treacher DF, Eykyn SJ. A 25-year study of nosocomial bacteremia in an adult intensive care unit. Crit Care Med 1999;27:1421-8. (Pubitemid 29406927)
6. Sligl W, Taylor G, Brindley PG. Five years of nosocomial gram-negative bacteremia in a general intensive care unit: epidemiology, antimicrobial susceptibility patterns, and outcomes. Int J Infect Dis 2006;10:320-5. (Pubitemid 43850827)
7. Warren DK, Zack JE, Elward AM, Cox MJ, Fraser VJ. Nosocomial primary bloodstream infections in intensive care unit patients in a nonteaching community medical center: a 21-month prospective study. Clin Infect Dis 2001;33:1329-35. (Pubitemid 32955182)
8. Thompson DS. Estimates of the rate of acquisition of bacteraemia and associated excess mortality in a general intensive care unit: a 10-year study. J Hosp Infect 2008;69:56-61.
9. Routsi C, Pratikaki M, Sotiropoulou C, Platsouka E, Markaki V, Paniara O, et al. Application of the sequential organ failure assessment (SOFA) score to bacteremic ICU patients. Infection 2007;35:240-4. (Pubitemid 47222279)
10. Harbarth S, Garbino J, Pugin J, Romand JA, Lew D, Pittet D. Inappropriate initial antimicrobial therapy and its effect on survival in a clinical trial of immunomodulating therapy for severe sepsis. Am J Med 2003; 115:529-35. (Pubitemid 37352798)
11. Falagas M, Koletsi PK, Kopterides P, Michalopoulos A. Risk factors for isolation of polymyxin-only susceptible (POS) strains among patients with Pseudomonas aeruginosa bacteremia. Antimicrob Agents Chemother 2006;50:2541-3. (Pubitemid 43993200)
12. Kopterides P, Koletsi P, Michalopoulos A, Falagas ME. Exposure to quinolones is associated with carbapenem resistance among colistin-susceptible Acinetobacter baumannii blood isolates. Int J Antimicrob Agents 2007;30:409-14. (Pubitemid 47498964)
13. Gaynes RP, Horan TC. Surveillance of nosocomial infections. Appendix A: CDC definitions of nosocomial infections. In: Mayhall CG, editor. Hospital epidemiology and infection control. Baltimore: Williams & Wilkins; 1996. p. 1-14.
14. Renaud B, Brun-Buisson C. ICU-Bacteremia Study Group. Outcomes of primary and catheter-related bacteremia: a cohort and case-control study in critically ill patients. Am J Respir Crit Care Med 2001;163: 1584-90. (Pubitemid 32578760)
15. Falagas ME, Bliziotis IA, Kasiakou SK, Samonis G, Athanassopoulou P, Michalopoulos A. Outcome of infections due to pandrug-resistant (PDR) gram-negative bacteria. BMC Infect Dis 2005;5:24.
16. Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, et al. International Sepsis Definitions Conference. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Intensive Care Med 2003;29:530-8.
17. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing. Twelfth Informational Supplement M100-S12. Wayne, PA: National Committee for Clinical Laboratory Standards; 2002.
18. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial disc susceptibility tests. Approved standard M2-A2 S2. Villanova, PA: National Committee for Clinical Laboratory Standards; 1981.
19. Methods for antimicrobial susceptibility testing. British Society for Antimicrobial Chemotherapy; Version 6.1, February 2007. Available from: http://www.bsac.org.uk/Resources/BSAC/version-6.1.pdf. Accessed October 19, 2010.
20. Blot S, Vandewoude K, Colardyn F. Nosocomial bacteremia involving Acinetobacter baumannii in critically ill patients: a matched cohort study. Intensive Care Med 2003;29:471-5. (Pubitemid 36379452)
21. Blot S, Vandewoude K, De Bacquer D, Colardyn F. Nosocomial bacteremia caused by antibiotic-resistant gram-negative bacteria in critically ill patients: clinical outcome and length of hospitalization. Clin Infect Dis 2002;34:1600-6. (Pubitemid 34615445)
22. Harbarth S, Ferrière K, Hugonnet S, Ricou B, Suter P, Pittet D. Epidemiology and prognostic determinants of bloodstream infections in surgical intensive care. Arch Surg 2002;137:1353-9. (Pubitemid 35429592)
23. Sreeramoju PV, Tolentino J, Garcia-Houchins S, Weber SG. Predictive factors for the development of central line-associated bloodstream infection due to gram-negative bacteria in intensive care unit patients after surgery. Infect Control Hosp Epidemiol 2008;29:51-6. (Pubitemid 351267774)
24. Thomsen RW, Hundborg HH, Lervang HH, Johnsen SP, Schønheyder HC, Sørensen HT. Diabetes mellitus as a risk and prognostic factor for community-acquired bacteremia due to enterobacteria: a 10-year, population-based study among adults. Clin Infect Dis 2005;40:628-31. (Pubitemid 40270239)
25. Joly-Guillou ML. Clinical impact and pathogenicity of Acinetobacter. Clin Microbiol Infect 2005;11:868-73.
26. Chen HY, Yuan M, Ibrahim-Elmagboul IB, Livermore DM. National survey of susceptibility to antimicrobials amongst clinical isolates of Pseudomonas aeruginosa. J Antimicrob Chemother 1995;35:521-34.